COL19A1 Antibody (N-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q14993 |
---|---|
Other Accession | NP_001849.2 |
Clone Names | 90904122 |
Gene ID | 1310 |
---|---|
Other Names | Collagen alpha-1(XIX) chain, Collagen alpha-1(Y) chain, COL19A1 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | COL19A1 |
---|---|
Function | May act as a cross-bridge between fibrils and other extracellular matrix molecules. Involved in skeletal myogenesis in the developing esophagus. May play a role in organization of the pericellular matrix or the sphinteric smooth muscle. |
Cellular Location | Secreted, extracellular space, extracellular matrix |
Tissue Location | Localized to vascular, neuronal, mesenchymal, and some epithelial basement membrane zones in umbilical cord |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
COL19A1 encodes the alpha chain of type XIX collagen, amember of the FACIT collagen family (fibril-associated collagenswith interrupted helices). Although the function of this collagenis not known, other members of this collagen family are found inassociation with fibril-forming collagens such as type I and II,and serve to maintain the integrity of the extracellular matrix.The transcript produced from this gene has an unusually large 3'UTR which has not been completely sequenced.
References
Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) :Barber, M.J., et al. PLoS ONE 5 (3), E9763 (2010) :Boudko, S.P., et al. J. Biol. Chem. 283(49):34345-34351(2008)Kapyla, J., et al. J. Biol. Chem. 279(49):51677-51687(2004)Mungall, A.J., et al. Nature 425(6960):805-811(2003)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.